Some Men at Risk for HIV Do Not Live Near PrEP Provider
Thirteen percent of PrEP-eligible men who have sex with men live in 30-minute-drive deserts
Vitamin D Supplementation Beneficial for Glucose Metabolism
Benefits on peripheral insulin sensitivity, disposition index for those at-risk or newly-diagnosed with T2DM
Review Supports Testosterone for Low Sexual Desire in Women
Beneficial effects for postmenopausal women, with preference for nonoral testosterone administration
Roxadustat Noninferior to Epoetin Alfa in Dialysis Patients
And for anemia in patients with kidney disease not undergoing dialysis, roxadustat is superior to placebo
FDA: Blood Clot, Death Risk Up With Higher Dose of Tofacitinib
Increased risk seen with 10 mg dose of tofacitinib used for treating ulcerative colitis
Testosterone Replacement Therapy May Increase Cardiovascular Risk
Increased risk in men on TRT for composite of heart attack, ischemic stroke, transient ischemic attack
FDA Approves First Noninjection Glucagon Therapy
Baqsimi nasal powder approved for emergency treatment of severe hypoglycemia in patients ≥4 years
Targeted Interventions Raise HPV Vaccine Acceptance in Women
Educational videos produced the highest rate of acceptability and knowledge
Minor Changes in BMD Seen With Tenofovir PrEP in Short Term
Those at high risk for fracture who plan prolonged PrEP use may wish to consider alternative strategies
Metformin May Lower Dementia Risk in Black Patients With T2DM
Findings strongest in younger African-American patients aged 50 to 64 years
